Fecal Microbiota Transplant for patients with recurring C. diff
Fecal Microbiota Transplant (FMT) has emerged as a successful treatment for patients with Clostridium difficile, commonly known as C. diff, given the therapy's approximate 90 percent effective rate.
FMT is a minimally invasive, same-day procedure that places the stool from a healthy person into the GI tract of an infected individual to repopulate the gut with healthy bacteria. FMT is performed through endoscopy/enteroscopy or colonoscopy and generally, only one procedure is required.
According to an article published by the American Association of Family Practice in April 2012, Clostridium difficile Infection Incidence, Costs Reach Historic Highs, the incidence of C. diff has tripled over the past decade.
Benefits of FMT
- Potentially improves the quality of life for C. diff patients
- Helps reduce overall cost of care for C. diff patients by shortening or eliminating hospitalizations and prescription expenses
Candidates for FMT
- Patients with documented recurrence of C. diff through repeat stool studies post antibiotic therapy
Find a Doctor
Patients confirmed with recurring C. diff may be referred for consultation with a gastroenterologist who performs FMT by calling 1.844.BSWDOCS (279.3627).